AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells
Srdan Verstovsek, Mirna Golemovic, Hagop Kantarjian, Tashi Manshouri, Zeev Estrov, Paul Manley, Tong Sun, Ralph B. Arlinghaus, Leila Alland, Margaret Dugan, Jorge Cortes, Francis Giles, Miloslav Beran*
Dive into the research topics of 'AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells'. Together they form a unique fingerprint.